Geoff Meacham
Stock Analyst at Citigroup
(4.42)
# 325
Out of 5,123 analysts
290
Total ratings
60.89%
Success rate
14.59%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Maintains: Neutral | $115 → $120 | $120.02 | -0.01% | 11 | Feb 4, 2026 | |
| AMGN Amgen | Maintains: Neutral | $315 → $345 | $366.36 | -5.83% | 14 | Feb 4, 2026 | |
| ABBV AbbVie | Maintains: Neutral | $235 → $230 | $218.59 | +5.22% | 22 | Jan 27, 2026 | |
| BIIB Biogen | Maintains: Neutral | $180 → $185 | $184.94 | +0.03% | 18 | Jan 27, 2026 | |
| GILD Gilead Sciences | Maintains: Buy | $140 → $156 | $149.82 | +4.12% | 9 | Jan 27, 2026 | |
| RPRX Royalty Pharma | Maintains: Buy | $48 → $50 | $43.77 | +14.25% | 4 | Jan 27, 2026 | |
| SRRK Scholar Rock Holding | Initiates: Buy | $55 | $44.69 | +23.07% | 1 | Jan 9, 2026 | |
| VOR Vor Biopharma | Initiates: Buy | $50 | $11.98 | +317.36% | 1 | Jan 9, 2026 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $80 → $110 | $74.97 | +46.73% | 7 | Dec 9, 2025 | |
| PTGX Protagonist Therapeutics | Maintains: Buy | $98 → $115 | $81.79 | +40.60% | 4 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $58 → $49 | $12.35 | +296.92% | 3 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Neutral | $26 | $26.91 | -3.36% | 7 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $2.23 | +258.74% | 6 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $75 | $71.65 | +4.68% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $660 → $700 | $773.40 | -9.49% | 24 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $75 → $72 | $72.79 | -1.09% | 8 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $28 | $40.52 | -30.90% | 11 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $50 | $32.20 | +55.28% | 2 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $50 | $42.30 | +18.20% | 4 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $20 | $13.37 | +49.59% | 5 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $93 | $46.20 | +101.30% | 4 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $550 → $575 | $460.09 | +24.98% | 6 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 → $14 | $6.96 | +101.15% | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $54 | $65.87 | -18.02% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $67.58 | +62.78% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $6 | $7.91 | -24.15% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $140 | $106.11 | +31.94% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $7 → $1 | $1.95 | -48.72% | 3 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $63.02 | +50.75% | 2 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $103 | $57.51 | +79.10% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $1.39 | +187.54% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $1,013.15 | +8.57% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $120 → $20 | $22.00 | -9.09% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $29.80 | +4.03% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $237.65 | -28.47% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $59.96 | +0.08% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $1.11 | +1,438.46% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $1.55 | +1,453.40% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $10.68 | -62.55% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $12.21 | +129.32% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $1.71 | +1,894.13% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $3.26 | +973.62% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $23.34 | +2,149.36% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $1.03 | +3,997.56% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $7.36 | +171.74% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.36 | +5,491.28% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $6.87 | +31.10% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $10.26 | +484.80% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $22.31 | +3.09% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $102.67 | -20.13% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $479.20 | -80.18% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $21.33 | +275.06% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $137.72 | -1.98% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $8.45 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $4.53 | +341.50% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $10.91 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $330.09 | -52.13% | 5 | Nov 8, 2017 |
Merck & Co.
Feb 4, 2026
Maintains: Neutral
Price Target: $115 → $120
Current: $120.02
Upside: -0.01%
Amgen
Feb 4, 2026
Maintains: Neutral
Price Target: $315 → $345
Current: $366.36
Upside: -5.83%
AbbVie
Jan 27, 2026
Maintains: Neutral
Price Target: $235 → $230
Current: $218.59
Upside: +5.22%
Biogen
Jan 27, 2026
Maintains: Neutral
Price Target: $180 → $185
Current: $184.94
Upside: +0.03%
Gilead Sciences
Jan 27, 2026
Maintains: Buy
Price Target: $140 → $156
Current: $149.82
Upside: +4.12%
Royalty Pharma
Jan 27, 2026
Maintains: Buy
Price Target: $48 → $50
Current: $43.77
Upside: +14.25%
Scholar Rock Holding
Jan 9, 2026
Initiates: Buy
Price Target: $55
Current: $44.69
Upside: +23.07%
Vor Biopharma
Jan 9, 2026
Initiates: Buy
Price Target: $50
Current: $11.98
Upside: +317.36%
Kymera Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $80 → $110
Current: $74.97
Upside: +46.73%
Protagonist Therapeutics
Dec 8, 2025
Maintains: Buy
Price Target: $98 → $115
Current: $81.79
Upside: +40.60%
Dec 2, 2025
Maintains: Buy
Price Target: $58 → $49
Current: $12.35
Upside: +296.92%
Dec 2, 2025
Reinstates: Neutral
Price Target: $26
Current: $26.91
Upside: -3.36%
Nov 18, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $2.23
Upside: +258.74%
Nov 5, 2025
Maintains: Neutral
Price Target: $50 → $75
Current: $71.65
Upside: +4.68%
Oct 29, 2025
Maintains: Buy
Price Target: $660 → $700
Current: $773.40
Upside: -9.49%
Oct 27, 2025
Downgrades: Neutral
Price Target: $75 → $72
Current: $72.79
Upside: -1.09%
Oct 23, 2025
Maintains: Neutral
Price Target: $30 → $28
Current: $40.52
Upside: -30.90%
Oct 17, 2025
Maintains: Buy
Price Target: $42 → $50
Current: $32.20
Upside: +55.28%
Oct 17, 2025
Maintains: Buy
Price Target: $45 → $50
Current: $42.30
Upside: +18.20%
Oct 17, 2025
Maintains: Buy
Price Target: $12 → $20
Current: $13.37
Upside: +49.59%
Oct 17, 2025
Maintains: Buy
Price Target: $78 → $93
Current: $46.20
Upside: +101.30%
Oct 2, 2025
Maintains: Buy
Price Target: $550 → $575
Current: $460.09
Upside: +24.98%
Aug 27, 2025
Upgrades: Buy
Price Target: $12 → $14
Current: $6.96
Upside: +101.15%
Jun 25, 2025
Maintains: Buy
Price Target: $50 → $54
Current: $65.87
Upside: -18.02%
Jun 17, 2025
Initiates: Buy
Price Target: $110
Current: $67.58
Upside: +62.78%
Jun 17, 2025
Initiates: Sell
Price Target: $6
Current: $7.91
Upside: -24.15%
May 6, 2025
Maintains: Buy
Price Target: $145 → $140
Current: $106.11
Upside: +31.94%
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $1.95
Upside: -48.72%
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $63.02
Upside: +50.75%
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $57.51
Upside: +79.10%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $1.39
Upside: +187.54%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $1,013.15
Upside: +8.57%
Oct 30, 2024
Downgrades: Underperform
Price Target: $120 → $20
Current: $22.00
Upside: -9.09%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $29.80
Upside: +4.03%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $237.65
Upside: -28.47%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $59.96
Upside: +0.08%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $1.11
Upside: +1,438.46%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $1.55
Upside: +1,453.40%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $10.68
Upside: -62.55%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $12.21
Upside: +129.32%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $1.71
Upside: +1,894.13%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $3.26
Upside: +973.62%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $23.34
Upside: +2,149.36%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $1.03
Upside: +3,997.56%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $7.36
Upside: +171.74%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.36
Upside: +5,491.28%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $6.87
Upside: +31.10%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $10.26
Upside: +484.80%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $22.31
Upside: +3.09%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $102.67
Upside: -20.13%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $479.20
Upside: -80.18%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $21.33
Upside: +275.06%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $137.72
Upside: -1.98%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $8.45
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $4.53
Upside: +341.50%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $10.91
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $330.09
Upside: -52.13%